New imaging technique to improve lung cancer treatment
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
This study is testing a new imaging technique that creates detailed maps of how your lungs work, which could help doctors plan better radiation treatments for lung cancer patients, aiming to protect healthy lung tissue and improve your overall experience during treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11017749 on NIH RePORTER |
What this research studies
This research focuses on developing a novel lung function imaging technique called 4DCT-ventilation, which aims to enhance the management of lung cancer patients undergoing radiation therapy. By creating detailed lung ventilation maps, this technique helps in planning radiation treatments that minimize damage to healthy lung tissue, potentially reducing severe side effects. The project involves collaboration between academic and industrial partners to translate this innovative imaging modality into clinical practice. Early-phase trials have shown promising results, indicating that this approach could lead to better patient outcomes and quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are lung cancer patients who are receiving or are scheduled to receive radiation therapy.
Not a fit: Patients who are not undergoing radiation therapy for lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the side effects of radiation therapy for lung cancer patients, improving their overall quality of life.
How similar studies have performed: Previous studies using similar imaging techniques have shown promising results, suggesting that this approach has the potential for success in clinical settings.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Vinogradskiy, Yevgeniy — Thomas Jefferson University
- Study coordinator: Vinogradskiy, Yevgeniy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.